149 related articles for article (PubMed ID: 25612063)
21. Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter.
Briegleb SK; Gulley JM; Hoover BR; Zahniser NR
Neuropsychopharmacology; 2004 Dec; 29(12):2168-79. PubMed ID: 15292903
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine.
Gozzi A; Large CH; Schwarz A; Bertani S; Crestan V; Bifone A
Neuropsychopharmacology; 2008 Jun; 33(7):1690-703. PubMed ID: 17805312
[TBL] [Abstract][Full Text] [Related]
23. Changes in brain volume in response to estradiol levels, amphetamine sensitization and haloperidol treatment in awake female rats.
Madularu D; Kulkarni P; Ferris CF; Brake WG
Brain Res; 2015 Aug; 1618():100-10. PubMed ID: 26032742
[TBL] [Abstract][Full Text] [Related]
24. Amphetamine-induced behavioral activation is associated with variable changes in basal ganglia output neurons recorded from awake, behaving rats.
Gulley JM; Reed JL; Kuwajima M; Rebec GV
Brain Res; 2004 Jun; 1012(1-2):108-18. PubMed ID: 15158167
[TBL] [Abstract][Full Text] [Related]
25. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
Adams BW; Bradberry CW; Moghaddam B
Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729
[TBL] [Abstract][Full Text] [Related]
26. Comparison of seven different anesthesia protocols for nicotine pharmacologic magnetic resonance imaging in rat.
Paasonen J; Salo RA; Shatillo A; Forsberg MM; Närväinen J; Huttunen JK; Gröhn O
Eur Neuropsychopharmacol; 2016 Mar; 26(3):518-31. PubMed ID: 26796682
[TBL] [Abstract][Full Text] [Related]
27. Amphetamine induces dopamine efflux through a dopamine transporter channel.
Kahlig KM; Binda F; Khoshbouei H; Blakely RD; McMahon DG; Javitch JA; Galli A
Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3495-500. PubMed ID: 15728379
[TBL] [Abstract][Full Text] [Related]
28. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
DeBoer P; Abercrombie ED
J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
[TBL] [Abstract][Full Text] [Related]
29. Brief exposure to obesogenic diet disrupts brain dopamine networks.
Barry RL; Byun NE; Williams JM; Siuta MA; Tantawy MN; Speed NK; Saunders C; Galli A; Niswender KD; Avison MJ
PLoS One; 2018; 13(4):e0191299. PubMed ID: 29698491
[TBL] [Abstract][Full Text] [Related]
30. S(+)amphetamine induces a persistent leak in the human dopamine transporter: molecular stent hypothesis.
Rodriguez-Menchaca AA; Solis E; Cameron K; De Felice LJ
Br J Pharmacol; 2012 Apr; 165(8):2749-57. PubMed ID: 22014068
[TBL] [Abstract][Full Text] [Related]
31. Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data.
Chen YC; Galpern WR; Brownell AL; Matthews RT; Bogdanov M; Isacson O; Keltner JR; Beal MF; Rosen BR; Jenkins BG
Magn Reson Med; 1997 Sep; 38(3):389-98. PubMed ID: 9339439
[TBL] [Abstract][Full Text] [Related]
32. Influence of chronic exercise on the amphetamine-induced dopamine release and neurodegeneration in the striatum of the rat.
Marques E; Vasconcelos F; Rolo MR; Pereira FC; Silva AP; Macedo TR; Ribeiro CF
Ann N Y Acad Sci; 2008 Oct; 1139():222-31. PubMed ID: 18991868
[TBL] [Abstract][Full Text] [Related]
33. Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates.
Nowak P; Brus R; Kostrzewa RM
Pol J Pharmacol; 2001; 53(4):319-29. PubMed ID: 11990078
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological MRI in awake rats reveals neural activity in area postrema and nucleus tractus solitarius: relevance as a potential biomarker for detecting drug-induced emesis.
Chin CL; Fox GB; Hradil VP; Osinski MA; McGaraughty SP; Skoubis PD; Cox BF; Luo Y
Neuroimage; 2006 Dec; 33(4):1152-60. PubMed ID: 17023182
[TBL] [Abstract][Full Text] [Related]
35. A multimodality investigation of cerebral hemodynamics and autoregulation in pharmacological MRI.
Gozzi A; Ceolin L; Schwarz A; Reese T; Bertani S; Crestan V; Bifone A
Magn Reson Imaging; 2007 Jul; 25(6):826-33. PubMed ID: 17451905
[TBL] [Abstract][Full Text] [Related]
36. Investigation of cross-species translatability of pharmacological MRI in awake nonhuman primate - a buprenorphine challenge study.
Seah S; Asad AB; Baumgartner R; Feng D; Williams DS; Manigbas E; Beaver JD; Reese T; Henry B; Evelhoch JL; Chin CL
PLoS One; 2014; 9(10):e110432. PubMed ID: 25337714
[TBL] [Abstract][Full Text] [Related]
37. Chronic exposure to manganese alters brain responses to amphetamine: a pharmacological magnetic resonance imaging study.
Williams JM; Milatovic D; Gore JC; Aschner M; Avison MJ
Toxicol Sci; 2010 Apr; 114(2):310-22. PubMed ID: 20061340
[TBL] [Abstract][Full Text] [Related]
38. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
Berridge CW; Stalnaker TA
Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
[TBL] [Abstract][Full Text] [Related]
39. TAK-063, a phosphodiesterase 10A inhibitor, modulates neuronal activity in various brain regions in phMRI and EEG studies with and without ketamine challenge.
Tomimatsu Y; Cash D; Suzuki M; Suzuki K; Bernanos M; Simmons C; Williams SC; Kimura H
Neuroscience; 2016 Dec; 339():180-190. PubMed ID: 27725212
[TBL] [Abstract][Full Text] [Related]
40. Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport.
Zaczek R; Culp S; De Souza EB
J Pharmacol Exp Ther; 1991 May; 257(2):830-5. PubMed ID: 1903446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
